Modified LIFT Versus Standard LIFT for Transsphincteric Anal Fistula
Modified LIFT Via a Lateral Approach Versus Standard LIFT for Transsphincteric Anal Fistula: A Prospective Randomized Study
調査の概要
詳細な説明
This was a prospective, single-center, randomized, parallel-group comparative surgical study conducted at the Department of General Surgery, Kayseri City Training and Research Hospital, Türkiye. The study included adult patients aged 18 to 75 years with magnetic resonance imaging-confirmed transsphincteric anal fistula who met the eligibility criteria and provided written informed consent.
Participants were randomly assigned in a 1:1 ratio to undergo either standard ligation of the intersphincteric fistula tract (LIFT) or modified LIFT via a lateral approach. All patients were evaluated by the same surgical team, and postoperative follow-up was performed at weeks 1, 4, 8, and 12.
The study compared early clinical outcomes between the two procedures, including wound healing time, early recurrence or persistence, postoperative pain, and fecal continence. The study was approved by the Kayseri City Hospital Clinical Research Ethics Committee before patient enrollment.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Kayseri
-
Kayseri、Kayseri、トルコ(Türkiye)、38300
- Kayseri City Training and Research Hospital
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Age 18 to 75 years
- Diagnosis of transsphincteric anal fistula confirmed by pelvic magnetic resonance imaging
- Presence of clinical findings consistent with perianal fistula, such as perianal discharge, palpable swelling, or history of perianal abscess drainage
- Ability and willingness to provide written informed consent
- Eligibility for surgical treatment with either standard LIFT or modified LIFT via a lateral approach
Exclusion Criteria:
- Previous definitive surgery for perianal fistula other than abscess drainage
- Perianal Crohn disease
- Horseshoe fistula
- Colorectal cancer
- Malnutrition
- Recurrent anal fistula
- Previous radiotherapy or chemotherapy
- Chronic medication use that could impair wound healing, such as steroids or colchicine
- Refusal or inability to provide written informed consent
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ:Modified LIFT via a Lateral Approach
Participants assigned to this arm underwent modified LIFT via a lateral approach.
The fistula tract was approached from the external opening, dissected and mobilized toward the internal sphincter level, excised at this level, and the remaining defect and internal opening were closed while preserving sphincter integrity.
|
Modified LIFT via a lateral approach was performed.
The fistula tract was approached from the external opening, dissected and mobilized toward the internal sphincter level, excised at that level, and the remaining defect and internal opening were closed.
|
|
アクティブコンパレータ:Standard LIFT
Participants assigned to this arm underwent standard ligation of the intersphincteric fistula tract (LIFT).
The intersphincteric plane was approached, and the fistula tract was identified, ligated, and divided according to the standard LIFT technique.
|
Standard ligation of the intersphincteric fistula tract was performed.
The intersphincteric plane was approached, and the fistula tract was identified, ligated, and divided according to the standard LIFT technique.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Wound Healing Time
時間枠:Up to 12 weeks after surgery
|
Time from surgery to complete clinical epithelialization of the perianal wound without discharge.
|
Up to 12 weeks after surgery
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Early Recurrence or Persistence of Anal Fistula
時間枠:Postoperative weeks 1, 4, 8, and 12
|
Presence of persistent or recurrent fistula-related symptoms or clinical findings during postoperative follow-up.
|
Postoperative weeks 1, 4, 8, and 12
|
|
Postoperative Pain Assessed Using the Visual Analog Scale
時間枠:Postoperative weeks 1, 4, 8, and 12
|
Postoperative pain will be assessed using the Visual Analog Scale.
The score ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
Higher scores indicate worse pain.
|
Postoperative weeks 1, 4, 8, and 12
|
|
Fecal Continence Assessed Using the Wexner Fecal Incontinence Score
時間枠:Postoperative weeks 1, 4, 8, and 12
|
Fecal continence will be assessed using the Wexner Fecal Incontinence Score.
The score ranges from 0 to 20, where 0 indicates perfect continence and 20 indicates complete fecal incontinence.
Higher scores indicate worse continence.
|
Postoperative weeks 1, 4, 8, and 12
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Tuğberk Tok, MD、Kayseri City Training and Research Hospital
- スタディディレクター:Yusuf Sevim, MD、Kayseri City Training and Research Hospital
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
追加の関連 MeSH 用語
その他の研究ID番号
- KCTRH-LIFT-944-2023
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。